Antigenics is exploiting heat shock proteins to trick the immune system into mounting a cancer-fighting response.
You may also be interested in...
The latest global vaccines summit has seen the launch of a new mechanism designed to spur the development of new coronavirus vaccines and ensure they are made available, particularly in low- and middle-income countries.
Progress for two US-based companies in the race to develop a COVID-19 vaccine.
BeiGene's BTK inhibitor for leukemia/lymphoma and Sanofi/Genzyme's enzyme replacement therapy for MPS I among novel drugs newly approved in China.